|
Dr. Stephen Howell is Professor of Medicine and Director of the Cancer Pharmacology Program at the University of California, San Diego. Dr. Howell is a leading physician scientist. He was trained as a medical oncologist and pharmacologist, and he runs a world-class research program that conducts both clinical and laboratory-based cancer research studies. The overall aim of Dr. Howell’s research is to improve the effectiveness of the treatment of cancer through the identification of strategies for preventing, overcoming, or reversing resistance to chemotherapeutic agents. Dr. Howell’s current clinical studies are testing novel strategies for delivery of increased amounts of drug to tumors. Dr. Howell is the author of more than 280 publications in the field of cancer chemotherapy. Dr. Howell received his M.D. degree from Harvard Medical School. He completed his internship and residency in medicine at the Massachusetts General Hospital, and then served in the U.S. Public Health Service as a research associate at the National Cancer Institute. Following a senior residency at the University of California, San Francisco, Dr. Howell completed training in medical oncology at the Dana Farber Cancer Institute. He joined the UCSD faculty in 1977. | 